Attenuated alloreactivity of dendritic cells engineered with surface-modified microspheres carrying a plasmid encoding interleukin-10
Source abstract
Abstract
In the present study, we investigated MS(O10H6) as a carrier system to introduce a plasmid encoding murine interleukin-10 (pIL-10) to modulate alloreactivity of dendritic cells (DC). Results indicate that MS(O10H6) formed stable and protective nano-sized particles with pIL-10. Gene-modified DC elicited weak proliferation of allogeneic CD4 and CD8 T cells in vitro. Using cell-embedded Matrigel as a surrogate graft, we also showed that DC transfected with MS(O10H6) complexed with pIL-10 suppressed host cell infiltration in vivo. These data demonstrate that the self-assembled system of MS(O10H6) is an effectual delivery vehicle for plasmid-based modulation of DC-dependent allogeneic T cell responses.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Immunotherapy and Immune Responses · RNA Interference and Gene Delivery · Antimicrobial Peptides and Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. The basis of immunogenicity of endocrine allografts10.1615/CritRevImmunol.v21.i1-3.60 ↗
2. Dendritic cell gene therapy10.1016/S1055-3207(02)00027-3 ↗
3. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC10.4049/jimmunol.174.10.5907 ↗
4. Dendritic cells: sentinels of immunity and tolerance10.1532/IJH97.04165 ↗
5. In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival10.1097/01.TP.0000122183.60680.C9 ↗
6. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo10.4049/jimmunol.166.6.3789 ↗
7. Gene therapy in transplantation10.1016/S0966-3274(02)00023-0 ↗
8. Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity10.1097/01.TP.0000067949.90241.CB ↗
9. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling10.1016/S1074-7613(00)80404-5 ↗
10. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes10.1084/jem.174.5.1209 ↗
11. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft10.4049/jimmunol.166.4.2385 ↗
12. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells10.1016/S0966-3274(03)00058-3 ↗
13. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity10.1182/blood.V99.7.2468 ↗
14. Designer dendritic cells for transplant tolerance10.1016/S0041-1345(02)03388-2 ↗
15. Gene transfer methods for transplantation10.1016/S0076-6879(02)46057-0 ↗
16. Efficiency, efficacy, and adverse effects of adenovirus vs. liposome-mediated gene therapy in cardiac allografts10.1152/ajpheart.2001.281.3.H1433 ↗
17. Dendritic cells transduced with viral interleukin 10 or Fas ligand: no evidence for induction of allotolerance in vivo10.1097/00007890-200201151-00010 ↗
18. Rapid rejection of HLA-A2 transgenic skin graft due to indirect allorecognition10.1097/00007890-200109270-00003 ↗
19. A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cells10.1016/j.molimm.2003.08.001 ↗
20. Polymeric microspheres as stabilizing anchors for oligonucleotide delivery to dendritic cells10.1016/j.biomaterials.2005.04.022 ↗
21. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor10.1084/jem.176.6.1693 ↗
22. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells
23. α-fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination
24. Determination of lymphocyte division by flow cytometry10.1016/0022-1759(94)90236-4 ↗
25. Novel in vivo murine model to study islet potency: engraftment and function10.1097/01.TP.0000159145.86990.44 ↗
26. Engineered heart tissue for regeneration of diseased hearts10.1016/S0142-9612(03)00521-0 ↗
27. Effect of the extracellular matrix on pancreatic endocrine cell function and its biocompatibility in dogs10.3727/000000001783986639 ↗
28. Matrigel treatment of primary hepatocytes following DNA transfection enhances responsiveness to extracellular stimuli
29. Transplantation of human prostatic carcinoma into nude mice in Matrigel
30. Matrigel augments xenograft transplantation of meningioma cells into athymic mice10.1097/00006123-199801000-00027 ↗
31. Cardiac grafting of engineered heart tissue in syngenic rats10.1161/01.cir.0000032876.55215.10 ↗
32. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma10.1021/bi00267a025 ↗
33. Correlation of anchorage—independent growth with tumorigenicity of chemically transformed mouse epidermal cells
34. The dendritic cell system and its role in immunogenicity10.1146/annurev.iy.09.040191.001415 ↗
35. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells10.4049/jimmunol.159.2.770 ↗